About
0.70USD-0.00 -0.14%
Closed • Updated at 13:34 GMT+00:00Market Cap$167.00M
P/E Ratio0.03
Volume134.8K
Beta-0.56
RSI32.04
Enlivex Ltd. — investor relations, events, news, and company updates on 6ix.
Latest News
May 15 2026
Enlivex Announces Receipt of Nasdaq Minimum Bid Price Notification
Apr 23 2026
Enlivex to Present Phase IIa 3-month and 6-month Data of Allocetra at OARSI 2026 World Congress
Apr 21 2026
Enlivex Announces Second Regulatory Approval for Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis
Apr 8 2026
Ondo Global Markets Tokenizes Enlivex’s Ordinary Shares
Mar 24 2026
Enlivex Announces $21 Million Debt Financing, Decentralized Prediction Markets RAIN Token-Related Updates and $20 Million Share Repurchase Program
Google Übersetzer